Document is current
Any future updates will be listed below
-
Authors
Lebedeva, Alexandra
Belova, Ekaterina https://orcid.org/0000-0002-7701-8765
Kavun, Alexandra
Taraskina, Anastasiia
Bartoletti, Michele
Bièche, Ivan
Curigliano, Giuseppe
Dupain, Célia
Rios-Hoyo, Alejandro
Kamal, Maud
Luchini, Claudio
Poyarkov, Stanislav
Le Tourneau, Christophe
Veselovsky, Egor
Mileyko, Vladislav
Ivanov, Maxim
- License Information
-
More Information
Article History
Accepted: 22 September 2024
First Online: 5 October 2024
Declarations
:
: This research received no external funding.
: Alexandra Lebedeva, Ekaterina Belova, Alexandra Kavun, Anastasia Taraskina, Egor Veselovsky, Vladislav Mileyko, and Maxim Ivanov are currently employed by OncoAtlas LLC. Stanislav Poyarkov is currently employed by Sistema BioTech. Claudio Luchini received funds from MSD and Medica s.r.l. (consulting, speakers bureau). Alejandro Rios-Hoyo reports travel accommodation by Novartis. Michele Bartoletti reports personal fees for advisory board from GSK, MSD and EISAI, ROCHE; speaker fees from GSK and AstraZeneca. Ivan Bièche, Giuseppe Curigliano, Célia Dupain, Maud Kamal, and Christophe Le Tourneau have no conflicts of interest that are directly relevant to the content of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: All data generated or analyzed during this study are included in this article.
: Not applicable.
: AL and MI designed the study. AL, AK, MB, IB, GC, CD, AR, MK, CL, SP, CLT, EV, and MI carried out the studies. AL, EB, and AK participated in collecting the data. AL, AT, and MI performed the data analysis. AL, AK, AT, and MI drafted the manuscript. VM provided administrative support. All authors contributed to manuscript revision and read and approved the submitted version.
